SCHEMBL16559367

SCHEMBL16559367

CNCC(O)C1c2cc(Cl)ccc2CCc2ccc(Cl)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 8/20 0.40
SLC6A4 P31645 8/20 0.40
HTR2C P28335 6/20 0.40
HTR2B P41595 6/20 0.40
HTR2A P28223 5/20 0.40
ADRB1 P08588 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
CNR1 P21554 1/20 0.40
HRH1 P35367 1/20 0.40
KCNH2 Q12809 1/20 0.40
HHAT Q5VTY9 1/20 0.36
SLC6A3 Q01959 1/20 0.35
TRPM5 Q9NZQ8 2/20 0.33
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CARM1 Q86X55 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16552473 0.87 SLC6A2 (0.42) SLC6A2SLC6A4HTR2CHTR2BHTR2A
SCHEMBL16559386 0.85 SLC6A2 (0.40) SLC6A2SLC6A4HTR2CHTR2BHTR2A
SCHEMBL16559364 0.82 HTR2A (0.40) SLC6A2SLC6A4HTR2CHTR2BHTR2A
SCHEMBL16559341 0.78 SLC6A2 (0.48) SLC6A2SLC6A4HTR2CHTR2AADRA2B
SCHEMBL10444192 0.74 HTR2C (0.49) SLC6A2SLC6A4HTR2CHTR2BHTR2A
SCHEMBL16571162 0.73 SLC6A2 (0.42) SLC6A2SLC6A4HTR2CHTR2BHTR2A
SCHEMBL16559366 0.72 SLC6A2 (0.36) SLC6A2SLC6A4SLC6A3CARM1
SCHEMBL16385860 0.68 HTR2C (0.58) SLC6A2SLC6A4HTR2CHTR2BHTR2A
SCHEMBL11866368 0.68 HTR2A (0.59) SLC6A2SLC6A4HTR2CHTR2BHTR2A
SCHEMBL16559388 0.66 SLC6A2 (0.39) SLC6A2HTR2AHRH1KCNH2CARM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210186969-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-06-24 US disclosed
US-10980805-B2 Aza-pyridone compounds and uses thereof Janssen Biopharma, Inc. (US) 2021-04-20 US disclosed
EP-3778603-A1 7,8-DIHYDRO-3H-PYRAZINO[1,2-B]PYRIDAZINE-3,5(6H)-DIONE COMPOUNDS AND USES THEREOF Janssen BioPharma, Inc. (US) 2021-02-17 EP disclosed
US-10702523-B2 AZA-pyridone compounds and uses thereof Janssen Biopharma, Inc. (US) 2020-07-07 US disclosed
US-20200030328-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2020-01-30 US disclosed
US-20190314373-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF ALIOS BIOPHARMA, INC. (US) 2019-10-17 US disclosed
US-10251882-B2 Aza-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-04-09 US disclosed
US-20160228438-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF ALIOS BIOPHARMA, INC. 2016-08-11 US disclosed
US-20160228438-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF ALIOS BIOPHARMA, INC. 2016-08-11 US disclosed
US-9328119-B2 AZA-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2016-05-03 US disclosed
WO-2015038655-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF ALIOS BIOPHARMA, INC. (US) 2015-03-19 WO disclosed
US-20150072982-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF Janssen Pharmaceuticals, Inc. 2015-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200030328-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885
US-10980805-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885
US-20190314373-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885
US-10251882-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885
US-20210186969-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885
US-10702523-B2 AZA-pyridone compounds and uses thereof PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885
US-20160228438-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885
US-20150072982-A1 AZA-PYRIDONE COMPOUNDS AND USES THEREOF PNPO, ITPA, PDXK SLC6A2 3848/4885SLC6A4 2473/4885HTR2C 2595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.